Telangiectasis: all 154 studies
Page 2 of 2. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- Cell-Based Approaches For Modeling and Treating Ataxia-TelangiectasiaTerminatedNCT02246491Not applicable
- Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)TerminatedNCT02106520Phase 2/3
- Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.CompletedNCT02104271Phase 2
- Laser Therapy Versus Electrosurgery For Nasal TelangiectasiasWithdrawnNCT02090517Not applicable
- Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular DiseasesStatus unknownNCT01975103Phase 2
- A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTelCompletedNCT01949324Phase 2
- International Ataxia Rating Scale in Younger PatientsCompletedNCT01942850
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Iron Deficiency and Hereditary Haemorrhagic TelangiectasiaTerminatedNCT01908543Not applicable
- QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye LaserCompletedNCT01803516
- The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic TelangiectasiaCompletedNCT01507480Phase 1
- Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic TelangiectasiaCompletedNCT01485224Phase 2
- Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)WithdrawnNCT01406639Phase 1
- The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)CompletedNCT01354093
- Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)CompletedNCT01327911Phase 1
- Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01314274Phase 2
- Treatment of Leg Telangiectasias With Nd:YAG 1064nmStatus unknownNCT01118390Not applicable
- Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia PatientsStatus unknownNCT01075438
- Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)Status unknownNCT01052623Phase 4
- Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01031992Phase 3
- The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied LongitudinallyStatus unknownNCT00951886
- Amantadine for Improving Neurologic Symptoms in Ataxia-TelangiectasiaCompletedNCT00950196Phase 4
- Study of Histological Samples From Patients With Hereditary Haemorrhagic TelangiectasiaCompletedNCT00733655
- Study of Endothelial Cells in Patients With Hereditary Haemorrhagic TelangiectasiaWithdrawnNCT00733629
- Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation TelangiectasiasCompletedNCT00725244Phase 4
- Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel GrowthCompletedNCT00685854Phase 1
- Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel GrowthCompletedNCT00685503Phase 1
- Screening Behavior in Adults With Hereditary Hemorrhagic TelangiectasiaCompletedNCT00684879
- Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)CompletedNCT00656409Phase 3
- Baclofen Treatment of Ataxia TelangiectasiaCompletedNCT00640003Early Phase 1
- Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)CompletedNCT00504400Phase 2
- Enhanced Safety Aesthetic Laser SystemStatus unknownNCT00495443Not applicable
- Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related MaculopathyCompletedNCT00470977Phase 1/2
- Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel FormationCompletedNCT00457145Phase 1
- Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel FormationCompletedNCT00457067Phase 1
- Intravitreal Bevacizumab for Idiopathic Macular TelangiectasiaCompletedNCT00451763Phase 3
- Effect of Avastin in Juxtafoveal TelangiectasiasWithdrawnNCT00406380Phase 3
- Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal BleedingCompletedNCT00389935Phase 2
- Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) TrialCompletedNCT00378196Phase 1
- Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical TrialCompletedNCT00375622Phase 2
- ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler SyndromeCompletedNCT00355108Phase 3
- Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE PlatformStatus unknownNCT00247299Not applicable
- Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMsCompletedNCT00230672
- Investigation of Coagulation Parameters in Hereditary Haemorrhagic TelangiectasiaCompletedNCT00230659
- Studies of White Blood Cells Derived From HHT PatientsActive, not recruitingNCT00230633
- Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).CompletedNCT00211328Phase 2
- Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin RednessStatus unknownNCT00206921Not applicable
- Study for Treatment of Cancer in Children With Ataxia-telangiectasiaCompletedNCT00187057Not applicable
- Epidemiology of Venous DiseaseCompletedNCT00005392
- Biobehavioral Determinants of Obesity in Black WomenCompletedNCT00005386
- Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic TelangiectasiaCompletedNCT00004654Phase 3
- Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia PatientsCompletedNCT00004649
- Studies of Hereditary Hemorrhagic TelangiectasiaCompletedNCT00004648
- Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile EctasiaCompletedNCT00004327Phase 2